We describe the first case from Norway of increased mortality in Atlantic salmon Salmo salar (L.), with septicaemia and necrotic myositis, associated with infection by Flavobacterium psychrophilum. The outbreak occurred in smolt of 60 to 100 g in fresh water on a landbased farm in Western Norway during winter 2008−2009. The water temperature was < 5°C and the accumulated mortality was 7.0%. Necropsy of dead and moribund fish revealed a swollen dark spleen, pale liver, serohaemorrhagic ascites and haemorrhage in the abdominal fat and muscle. F. psychrophilum was isolated from the kidney and spleen of diseased fish. Muscle biopsy revealed the presence of long filamentous rods in necrotic areas of skeletal muscle. Immunohistochemistry was positive for F. psychrophilum. Identification of cultured isolates as F. psychrophilum was confirmed using phenotypic testing and sequencing of the 16S rRNA gene. Analysis by allele-specific polymerase chain reaction (allele-specific PCR) indicated that 2 different genotypes of the bacterium were present in the outbreak.KEY WORDS: Flavobacterium psychrophilum · Atlantic salmon · Necrotic myositis · Septicaemia · 16S rRNA allele
Resale or republication not permitted without written consent of the publisherDis Aquat Org 97: 37-46, 2011 38 brown trout Salmo trutta (L.) (Johansen et al. 2009). On a worldwide basis, although isolations of F. psychrophilum from Atlantic salmon are not uncommon, reports of systemic infections are scarce, lending support to observations that this species of fish is less susceptible to this disease (Holt et al. 1993, Schmidtke & Carson 1995, Ekman et al. 1999, Valdebenito & Avendaño-Herrera 2009. To the best of our knowledge the present paper describes the first case in which F. psychrophilum has been associated with septicaemia and necrotic myositis in Atlantic salmon in Norway.
MATERIALS AND METHODSCase history. The disease was first detected in late autumn 2008 in a group of 82 000 Atlantic salmon smolts of 60 to 100 g in a land-based unit in Western Norway. The water temperature was < 5°C. Owing to limited resources of fresh water, UV-treated sea water was used to buffer the fresh water, resulting in salinity of approximately 2 to 3 ‰.The fry were hatched in December 2007 at a freshwater site located in the same region; they were moved to the unit at the beginning of January 2008. Vaccination against infectious pancreatic necrosis was performed in April (AquaVac ® IPN Oral), and against furunculosis, vibriosis, coldwater vibriosis, Moritella viscosa infection and infectious pancreatic necrosis in August (Alphaject 6-2 ® , polyvalent i.p. vaccine). Despite completion of smoltification by October 2008, transfer of the smolts to sea water was delayed until the spring of 2009. Owing to this delay, the fish were revaccinated in November and December with a polyvalent i.p. vaccine against pancreatic disease (Norvax ® Compact PD) at 1.5 to 2°C. The mortality started to increase at the end of November, 2008, and remained elevated through December...